Accuracy of FENO for diagnosing asthma: a systematic review. 2017

Stefan Karrasch, and Klaus Linde, and Gerta Rücker, and Harriet Sommer, and Marlies Karsch-Völk, and Jos Kleijnen, and Rudolf A Jörres, and Antonius Schneider
Institute of General Practice, University Hospital Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Measurement of FENO might substitute bronchial provocation for diagnosing asthma. We aimed to investigate the diagnostic accuracy of FENO measurement compared with established reference standard. Systematic review and diagnostic meta-analysis. Data sources were Medline, Embase and Scopus up to 29 November 2015. Sensitivity and specificity were estimated using a bivariate model. Additionally, summary receiver-operating characteristic curves were estimated. 26 studies with 4518 participants (median 113) were included. Risk of bias was considered low for six of seven items in five studies and for five items in seven studies. The overall sensitivity in the meta-analysis was 0.65 (95% CI 0.58 to 0.72), the overall specificity 0.82 (0.76 to 0.86), the diagnostic OR 9.23 (6.55 to 13.01) and the area under the curve 0.80 (0.77 to 0.85). In meta-regression analyses, higher cut-off values were associated with increasing specificity (OR 1.46 per 10 ppb increase in cut-off) while there was no association with sensitivity. Sensitivities varied significantly within the different FENO devices, but not specificities. Neither prevalence, age, use of bronchoprovocation in >90% of participants or as exclusive reference standard test, nor risk of bias were significantly associated with diagnostic accuracy. There appears to be a fair accuracy of FENO for making the diagnosis of asthma. The overall specificity was higher than sensitivity, which indicates a higher diagnostic potential for ruling in than for ruling out the diagnosis of asthma.

UI MeSH Term Description Entries
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D001944 Breath Tests Any tests done on exhaled air. Breathalyzer Tests,Breath Test,Breathalyzer Test,Test, Breath,Test, Breathalyzer,Tests, Breath,Tests, Breathalyzer
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

Stefan Karrasch, and Klaus Linde, and Gerta Rücker, and Harriet Sommer, and Marlies Karsch-Völk, and Jos Kleijnen, and Rudolf A Jörres, and Antonius Schneider
February 2013, Respiratory medicine,
Stefan Karrasch, and Klaus Linde, and Gerta Rücker, and Harriet Sommer, and Marlies Karsch-Völk, and Jos Kleijnen, and Rudolf A Jörres, and Antonius Schneider
June 2022, Children (Basel, Switzerland),
Stefan Karrasch, and Klaus Linde, and Gerta Rücker, and Harriet Sommer, and Marlies Karsch-Völk, and Jos Kleijnen, and Rudolf A Jörres, and Antonius Schneider
January 2015, Medicine,
Stefan Karrasch, and Klaus Linde, and Gerta Rücker, and Harriet Sommer, and Marlies Karsch-Völk, and Jos Kleijnen, and Rudolf A Jörres, and Antonius Schneider
August 2023, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
Stefan Karrasch, and Klaus Linde, and Gerta Rücker, and Harriet Sommer, and Marlies Karsch-Völk, and Jos Kleijnen, and Rudolf A Jörres, and Antonius Schneider
April 2010, Annals of internal medicine,
Stefan Karrasch, and Klaus Linde, and Gerta Rücker, and Harriet Sommer, and Marlies Karsch-Völk, and Jos Kleijnen, and Rudolf A Jörres, and Antonius Schneider
April 2023, JPMA. The Journal of the Pakistan Medical Association,
Stefan Karrasch, and Klaus Linde, and Gerta Rücker, and Harriet Sommer, and Marlies Karsch-Völk, and Jos Kleijnen, and Rudolf A Jörres, and Antonius Schneider
June 2022, Clinical nutrition (Edinburgh, Scotland),
Stefan Karrasch, and Klaus Linde, and Gerta Rücker, and Harriet Sommer, and Marlies Karsch-Völk, and Jos Kleijnen, and Rudolf A Jörres, and Antonius Schneider
January 2017, The journal of allergy and clinical immunology. In practice,
Stefan Karrasch, and Klaus Linde, and Gerta Rücker, and Harriet Sommer, and Marlies Karsch-Völk, and Jos Kleijnen, and Rudolf A Jörres, and Antonius Schneider
November 2022, Cureus,
Stefan Karrasch, and Klaus Linde, and Gerta Rücker, and Harriet Sommer, and Marlies Karsch-Völk, and Jos Kleijnen, and Rudolf A Jörres, and Antonius Schneider
October 2022, Seminars in respiratory and critical care medicine,
Copied contents to your clipboard!